{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:46:32Z","timestamp":1769283992300,"version":"3.49.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["R.G.P.2\/410\/46"],"award-info":[{"award-number":["R.G.P.2\/410\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12012-025-10078-4","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T08:11:39Z","timestamp":1766477499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanomedicine-Based Strategies for Mitigating Chemo\/Radiotherapy-Induced Cardiac Inflammation and Fibrosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Safia Obaidur","family":"Rab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa","family":"AlKhafaje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday Abdul-Reda","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa","family":"Adel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola Kamal A.","family":"Alkadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Aldulaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakir Mahmood","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waam Mohammed","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseel","family":"Smerat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"1","key":"10078_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/anticanres.14746","volume":"41","author":"KS Rallis","year":"2021","unstructured":"Rallis, K. S., Yau, T. H. L., & Sideris, M. (2021). Chemoradiotherapy in cancer treatment: Rationale and clinical applications. Anticancer Research, 41(1), 1\u20137.","journal-title":"Anticancer Research"},{"issue":"3","key":"10078_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1874471016666230214101830","volume":"16","author":"K Singh","year":"2023","unstructured":"Singh, K., Alameri, A., Ali Hamza, A., Al-Gazally, E., Temurovich Islomov, S., Fadhel Obaid, R., Alexis Ramirez-Coronel, A., Abosaooda, M., Yahyapour, R., & Najafi, M. (2023). Cardiac injury following chemo\/radiation therapy: An updated review on mechanisms and therapeutic approaches. Current Radiopharmaceuticals, 16(3), 185\u2013203.","journal-title":"Current Radiopharmaceuticals"},{"key":"10078_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.radonc.2022.05.007","volume":"172","author":"M Kearney","year":"2022","unstructured":"Kearney, M., Keys, M., Faivre-Finn, C., Wang, Z., Aznar, M. C., & Duane, F. (2022). Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020. Radiotherapy and Oncology, 172, 118\u2013125.","journal-title":"Radiotherapy and Oncology"},{"issue":"4","key":"10078_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","volume":"93","author":"CW Taylor","year":"2015","unstructured":"Taylor, C. W., Wang, Z., Macaulay, E., Jagsi, R., Duane, F., & Darby, S. C. (2015). Exposure of the heart in breast cancer radiation therapy: A systematic review of heart doses published during 2003 to 2013. International Journal of Radiation Oncology*Biology*Physics, 93(4), 845\u2013853.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"1","key":"10078_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10787-021-00894-9","volume":"30","author":"R Yang","year":"2022","unstructured":"Yang, R., Tan, C., & Najafi, M. (2022). Cardiac inflammation and fibrosis following chemo\/radiation therapy: Mechanisms and therapeutic agents. Inflammopharmacology, 30(1), 73\u201389.","journal-title":"Inflammopharmacology"},{"issue":"24","key":"10078_CR6","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1002\/cncr.33860","volume":"127","author":"JL Jefferies","year":"2021","unstructured":"Jefferies, J. L., Mazur, W. M., Howell, C. R., Plana, J. C., Ness, K. K., Li, Z., Joshi, V. M., Green, D. M., Mulrooney, D. A., & Towbin, J. A. (2021). Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Cancer, 127(24), 4646\u20134655.","journal-title":"Cancer"},{"issue":"9","key":"10078_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12012-022-09762-6","volume":"22","author":"T Panpan","year":"2022","unstructured":"Panpan, T., Yuchen, D., Xianyong, S., Meng, L., Ruijuan, H., Ranran, D., Pengyan, Z., Mingxi, L., & Rongrong, X. (2022). Cardiac remodelling following cancer therapy: A review. Cardiovascular Toxicology, 22(9), 771\u2013786.","journal-title":"Cardiovascular Toxicology"},{"issue":"15","key":"10078_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/ars.2020.8016","volume":"32","author":"C Rocca","year":"2020","unstructured":"Rocca, C., Pasqua, T., Cerra, M. C., & Angelone, T. (2020). Cardiac damage in anthracyclines therapy: Focus on oxidative stress and inflammation. Antioxidants & Redox Signaling, 32(15), 1081\u20131097.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"3","key":"10078_CR9","first-page":"583","volume":"18","author":"LK Liu","year":"2017","unstructured":"Liu, L. K., Ouyang, W., Zhao, X., Su, S. F., Yang, Y., Ding, W. J., Luo, D. X., He, Z. X., & Lu, B. (2017). Pathogenesis and prevention of radiation-induced myocardial fibrosis. Asian Pacific Journal of Cancer Prevention: APJCP, 18(3), 583.","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP"},{"issue":"1","key":"10078_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.annonc.2019.10.003","volume":"31","author":"D De Ruysscher","year":"2020","unstructured":"De Ruysscher, D., Faivre-Finn, C., Nackaerts, K., Jordan, K., Arends, J., Douillard, J.-Y., Ricardi, U., & Peters, S. (2020). Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer. Annals of Oncology, 31(1), 41\u201349.","journal-title":"Annals of Oncology"},{"issue":"7","key":"10078_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1089\/ars.2020.8055","volume":"34","author":"C Cadeddu Dessalvi","year":"2021","unstructured":"Cadeddu Dessalvi, C., Deidda, M., Noto, A., Madeddu, C., Cugusi, L., Santoro, C., L\u00f3pez-Fern\u00e1ndez, T., Galderisi, M., & Mercuro, G. (2021). Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity. Antioxidants & Redox Signaling, 34(7), 572\u2013588.","journal-title":"Antioxidants & Redox Signaling"},{"key":"10078_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117264","volume":"244","author":"K Li","year":"2024","unstructured":"Li, K., Chen, W., Ma, L., Yan, L., & Wang, B. (2024). Approaches for reducing chemo\/radiation-induced cardiotoxicity by nanoparticles. Environmental Research, 244, Article 117264.","journal-title":"Environmental Research"},{"issue":"12","key":"10078_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","volume":"104","author":"PA Henriksen","year":"2018","unstructured":"Henriksen, P. A. (2018). Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart, 104(12), 971\u2013977.","journal-title":"Heart"},{"issue":"4","key":"10078_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41416-024-02888-0","volume":"132","author":"GM Walls","year":"2025","unstructured":"Walls, G. M., Bergom, C., Mitchell, J. D., Rentschler, S. L., Hugo, G. D., Samson, P. P., & Robinson, C. G. (2025). Cardiotoxicity following thoracic radiotherapy for lung cancer. British Journal of Cancer, 132(4), 311\u2013325.","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10078_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","volume":"31","author":"JV McGowan","year":"2017","unstructured":"McGowan, J. V., Chung, R., Maulik, A., Piotrowska, I., Walker, J. M., & Yellon, D. M. (2017). Anthracycline chemotherapy and cardiotoxicity. Cardiovascular Drugs and Therapy, 31(1), 63\u201375.","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"2","key":"10078_CR16","first-page":"93","volume":"19","author":"D Mozdzanowska","year":"2015","unstructured":"Mozdzanowska, D., & Wo\u017aniewski, M. (2015). Radiotherapy and anthracyclines - cardiovascular toxicity. Contemporary Oncology (Poznan), 19(2), 93\u201397.","journal-title":"Contemporary Oncology (Poznan)"},{"key":"10078_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijcard.2016.02.137","volume":"212","author":"MT Nolan","year":"2016","unstructured":"Nolan, M. T., Plana, J. C., Thavendiranathan, P., Shaw, L., Si, L., & Marwick, T. H. (2016). Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity. International Journal of Cardiology, 212, 336\u2013345.","journal-title":"International Journal of Cardiology"},{"issue":"7","key":"10078_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036649","volume":"14","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Song, J., Hanif, W., Clark, R., Haroun, M., Dandamudi, M., Simoza, P. G., Slipczuk, L., Garcia, M. J., Pu, M., Gongora, C. A., Neilan, T. G., Makower, D. F., Chambers, E. C., & Rodriguez, C. J. (2025). Associations between Social Determinants of Health, allostatic load, and anthracycline cardiotoxicity in a diverse patient population. Journal of the American Heart Association, 14(7), Article e036649.","journal-title":"Journal of the American Heart Association"},{"issue":"24","key":"10078_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023852","volume":"10","author":"RE Ohman","year":"2021","unstructured":"Ohman, R. E., Yang, E. H., & Abel, M. L. (2021). Inequity in cardio-oncology: Identifying disparities in cardiotoxicity and links to cardiac and cancer outcomes. Journal of the American Heart Association, 10(24), Article e023852.","journal-title":"Journal of the American Heart Association"},{"key":"10078_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117570","volume":"250","author":"B Farhood","year":"2020","unstructured":"Farhood, B., Ashrafizadeh, M., khodamoradi, E., Hoseini-Ghahfarokhi, M., Afrashi, S., Musa, A. E., & Najafi, M. (2020). Targeting of cellular redox metabolism for mitigation of radiation injury. Life Sciences, 250, Article 117570.","journal-title":"Life Sciences"},{"key":"10078_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1353990","volume":"15","author":"S Yamaga","year":"2024","unstructured":"Yamaga, S., Aziz, M., Murao, A., Brenner, M., & Wang, P. (2024). DAMPs and radiation injury. Frontiers in Immunology, 15, Article 1353990.","journal-title":"Frontiers in Immunology"},{"issue":"13","key":"10078_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137477","volume":"25","author":"R Vitale","year":"2024","unstructured":"Vitale, R., Marzocco, S., & Popolo, A. (2024). Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: A brief account. International Journal of Molecular Sciences, 25(13), Article 7477.","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10078_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28114294","volume":"28","author":"N Sumneang","year":"2023","unstructured":"Sumneang, N., Tanajak, P., & Oo, T. T. (2023). Toll-like receptor 4 inflammatory perspective on doxorubicin-induced cardiotoxicity. Molecules, 28(11), Article 4294.","journal-title":"Molecules"},{"issue":"8","key":"10078_CR24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/cdd.2011.4","volume":"18","author":"DV Krysko","year":"2011","unstructured":"Krysko, D. V., Kaczmarek, A., Krysko, O., Heyndrickx, L., Woznicki, J., Bogaert, P., Cauwels, A., Takahashi, N., Magez, S., & Bachert, C. (2011). TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation. Cell Death & Differentiation, 18(8), 1316\u20131325.","journal-title":"Cell Death & Differentiation"},{"issue":"3","key":"10078_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2174\/0109298673262122231011172100","volume":"32","author":"J Gupta","year":"2025","unstructured":"Gupta, J., Almulla, A. F., Jalil, A. T., Jasim, N. Y., Aminov, Z., Alsaikhan, F., Ramaiah, P., Chinnasamy, L., & Jawhar, Z. H. (2025). Melatonin in chemo\/radiation therapy; Implications for normal tissues sparing and tumor suppression: An updated review. Current Medicinal Chemistry, 32(3), 511\u2013538.","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"10078_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00066-018-1382-3","volume":"195","author":"RH Preidl","year":"2019","unstructured":"Preidl, R. H., M\u00f6bius, P., Weber, M., Amann, K., Neukam, F. W., Kesting, M., Geppert, C.-I., & Wehrhan, F. (2019). Long-term endothelial dysfunction in irradiated vessels: An immunohistochemical analysis. Strahlentherapie und Onkologie, 195(1), 52\u201361.","journal-title":"Strahlentherapie und Onkologie"},{"issue":"3","key":"10078_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cyto.2009.08.007","volume":"48","author":"CC Chang","year":"2009","unstructured":"Chang, C. C., Lerman, O. Z., Thanik, V. D., Scharf, C. L., Greives, M. R., Schneider, R. J., Formenti, S. C., Saadeh, P. B., Warren, S. M., & Levine, J. P. (2009). Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells. Cytokine, 48(3), 295\u2013302.","journal-title":"Cytokine"},{"issue":"1","key":"10078_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02038-x","volume":"17","author":"L Wang","year":"2022","unstructured":"Wang, L., Jiang, J., Chen, Y., Jia, Q., & Chu, Q. (2022). The roles of CC chemokines in response to radiation. Radiation Oncology, 17(1), Article 63.","journal-title":"Radiation Oncology"},{"issue":"7","key":"10078_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070317","volume":"55","author":"B Farhood","year":"2019","unstructured":"Farhood, B., Aliasgharzadeh, A., Amini, P., Saffar, H., Motevaseli, E., Rezapoor, S., Nouruzi, F., Shabeeb, D., Eleojo Musa, A., & Ashabi, G. (2019). Radiation-induced dual oxidase upregulation in rat heart tissues: Protective effect of melatonin. Medicina (Kaunas), 55(7), Article 317.","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10078_CR30","first-page":"193","volume":"7","author":"R Yahyapour","year":"2018","unstructured":"Yahyapour, R., Amini, P., Saffar, H., Rezapoor, S., Motevaseli, E., Cheki, M., Farhood, B., Nouruzi, F., Shabeeb, D., & Musa, A. E. (2018). Metformin protects against radiation-induced heart injury and attenuates the upregulation of dual oxidase genes following rat\u2019s chest irradiation. International Journal of Molecular and Cellular Medicine, 7(3), 193.","journal-title":"International Journal of Molecular and Cellular Medicine"},{"issue":"22","key":"10078_CR31","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","volume":"70","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A. P., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. J. (2010). Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Research, 70(22), 9287\u20139297.","journal-title":"Cancer Research"},{"key":"10078_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.freeradbiomed.2018.03.053","volume":"120","author":"K Iwata","year":"2018","unstructured":"Iwata, K., Matsuno, K., Murata, A., Zhu, K., Fukui, H., Ikuta, K., Katsuyama, M., Ibi, M., Matsumoto, M., & Ohigashi, M. (2018). Up-regulation of NOX1\/NADPH oxidase following drug-induced myocardial injury promotes cardiac dysfunction and fibrosis. Free Radical Biology and Medicine, 120, 277\u2013288.","journal-title":"Free Radical Biology and Medicine"},{"issue":"3","key":"10078_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1667\/RR13799.1","volume":"183","author":"U Weyemi","year":"2015","unstructured":"Weyemi, U., Redon, C. E., Aziz, T., Choudhuri, R., Maeda, D., Parekh, P. R., Bonner, M. Y., Arbiser, J. L., & Bonner, W. M. (2015). Inactivation of NADPH oxidases NOX4 and NOX5 protects human primary fibroblasts from ionizing radiation-induced DNA damage. Radiation Research, 183(3), 262\u2013270.","journal-title":"Radiation Research"},{"key":"10078_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-030-71155-9_6","volume-title":"Clinical cases in cardio-oncology","author":"A Rohani","year":"2021","unstructured":"Rohani, A. (2021). Doxorubicin induced heart failure with reduced ejection fraction. Clinical cases in cardio-oncology (pp. 21\u201327). Springer."},{"issue":"9","key":"10078_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1192-y","volume":"21","author":"N Szpakowski","year":"2019","unstructured":"Szpakowski, N., & Desai, M. Y. (2019). Radiation-associated pericardial disease. Current Cardiology Reports, 21(9), Article 97.","journal-title":"Current Cardiology Reports"},{"key":"10078_CR36","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2022.44","volume":"12","author":"R Bedi","year":"2023","unstructured":"Bedi, R., Ahmad, A., Horbal, P., & Mar, P. L. (2023). Radiation-associated arrhythmias: Putative pathophysiological mechanisms, prevalence, screening and management strategies. Arrhythmia & Electrophysiology Review, 12, Article e24.","journal-title":"Arrhythmia & Electrophysiology Review"},{"issue":"1","key":"10078_CR37","volume":"2023","author":"Z Ping","year":"2023","unstructured":"Ping, Z., Fangfang, T., Yuliang, Z., Xinyong, C., Lang, H., Fan, H., Jun, M., & Liang, S. (2023). Oxidative stress and pyroptosis in doxorubicin-induced heart failure and atrial fibrillation. Oxidative Medicine and Cellular Longevity, 2023(1), Article 4938287.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10078_CR38","volume":"9","author":"MW Bloom","year":"2016","unstructured":"Bloom, M. W., Hamo, C. E., Cardinale, D., Ky, B., Nohria, A., Baer, L., Skopicki, H., Lenihan, D. J., Gheorghiade, M., & Lyon, A. R. (2016). Cancer therapy\u2013related cardiac dysfunction and heart failure: Part 1: Definitions, pathophysiology, risk factors, and imaging. Circulation: Heart Failure, 9(1), Article e002661.","journal-title":"Circulation: Heart Failure"},{"issue":"10","key":"10078_CR39","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.hlc.2018.08.003","volume":"28","author":"SP Levick","year":"2019","unstructured":"Levick, S. P., Soto-Pantoja, D. R., Bi, J., Hundley, W. G., Widiapradja, A., Manteufel, E. J., Bradshaw, T. W., & Mel\u00e9ndez, G. C. (2019). Doxorubicin-induced myocardial fibrosis involves the neurokinin-1 receptor and direct effects on cardiac fibroblasts. Heart, Lung and Circulation, 28(10), 1598\u20131605.","journal-title":"Heart, Lung and Circulation"},{"issue":"1","key":"10078_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01077-5","volume":"21","author":"S Shi","year":"2023","unstructured":"Shi, S., Chen, Y., Luo, Z., Nie, G., & Dai, Y. (2023). Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. Cell Communication and Signaling, 21(1), Article 61.","journal-title":"Cell Communication and Signaling"},{"issue":"1","key":"10078_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00858-z","volume":"30","author":"S Chen","year":"2024","unstructured":"Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., & Liu, J. (2024). Modulation of anti-cardiac fibrosis immune responses by changing M2 macrophages into M1 macrophages. Molecular Medicine, 30(1), Article 88.","journal-title":"Molecular Medicine"},{"issue":"6","key":"10078_CR42","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016). Cardiac fibrosis: The fibroblast awakens. Circulation Research, 118(6), 1021\u20131040.","journal-title":"Circulation Research"},{"issue":"5","key":"10078_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051294","volume":"19","author":"L Caja","year":"2018","unstructured":"Caja, L., Dituri, F., Mancarella, S., Caballero-Diaz, D., Moustakas, A., Giannelli, G., & Fabregat, I. (2018). TGF-\u03b2 and the tissue microenvironment: Relevance in fibrosis and cancer. International Journal of Molecular Sciences, 19(5), Article 1294.","journal-title":"International Journal of Molecular Sciences"},{"issue":"16","key":"10078_CR44","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2174\/1389450123666220907144131","volume":"23","author":"C Xu","year":"2022","unstructured":"Xu, C., Shang, Z., & Najafi, M. (2022). Lung pneumonitis and fibrosis in cancer therapy: A review on cellular and molecular mechanisms. Current Drug Targets, 23(16), 1505\u20131525.","journal-title":"Current Drug Targets"},{"issue":"1","key":"10078_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1874471011666180831101459","volume":"12","author":"S Kolivand","year":"2019","unstructured":"Kolivand, S., Amini, P., Saffar, H., Rezapoor, S., Motevaseli, E., Najafi, M., Nouruzi, F., Shabeeb, D., & Musa, A. E. (2019). Evaluating the radioprotective effect of curcumin on rat\u2019s heart tissues. Current Radiopharmaceuticals, 12(1), 23\u201328.","journal-title":"Current Radiopharmaceuticals"},{"issue":"3","key":"10078_CR46","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s12013-024-01384-9","volume":"82","author":"SM Mohammed","year":"2024","unstructured":"Mohammed, S. M., Al-Saedi, H. F. S., Mohammed, A. Q., Amir, A. A., Radi, U. K., Sattar, R., Ahmad, I., Ramadan, M. F., Alshahrani, M. Y., & Balasim, H. M. (2024). Mechanisms of bleomycin-induced lung fibrosis: A review of therapeutic targets and approaches. Cell Biochemistry and Biophysics, 82(3), 1845\u20131870.","journal-title":"Cell Biochemistry and Biophysics"},{"issue":"4","key":"10078_CR47","doi-asserted-by":"publisher","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","volume":"308","author":"F Liu","year":"2015","unstructured":"Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinkovi\u0107, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., & Horowitz, J. C. (2015). Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology, 308(4), L344\u2013L357.","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10078_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021). Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine & Pharmacotherapy, 139, Article 111708.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"10","key":"10078_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101657","volume":"11","author":"JC Bachmann","year":"2022","unstructured":"Bachmann, J. C., Baumgart, S. J., Uryga, A. K., Bosteen, M. H., Borghetti, G., Nyberg, M., & Herum, K. M. (2022). Fibrotic signaling in cardiac fibroblasts and vascular smooth muscle cells: The dual roles of fibrosis in HFpEF and CAD. Cells, 11(10), Article 1657.","journal-title":"Cells"},{"issue":"4","key":"10078_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/ehjci\/jead340","volume":"25","author":"GE Mandoli","year":"2024","unstructured":"Mandoli, G. E., Cameli, M., Pastore, M. C., Loiacono, F., Righini, F. M., D\u2019Ascenzi, F., Focardi, M., Cavigli, L., Lisi, M., & Bisleri, G. (2024). Left ventricular fibrosis as a main determinant of filling pressures and left atrial function in advanced heart failure. European Heart Journal-Cardiovascular Imaging, 25(4), 446\u2013453.","journal-title":"European Heart Journal-Cardiovascular Imaging"},{"issue":"5","key":"10078_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tcm.2017.01.011","volume":"27","author":"M Disertori","year":"2017","unstructured":"Disertori, M., Mas\u00e8, M., & Ravelli, F. (2017). Myocardial fibrosis predicts ventricular tachyarrhythmias. Trends in Cardiovascular Medicine, 27(5), 363\u2013372.","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"8","key":"10078_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1162-4","volume":"21","author":"GA Fishbein","year":"2019","unstructured":"Fishbein, G. A., & Fishbein, M. C. (2019). Pathology of the aortic valve: Aortic valve stenosis\/aortic regurgitation. Current Cardiology Reports, 21(8), Article 81.","journal-title":"Current Cardiology Reports"},{"issue":"7","key":"10078_CR53","first-page":"1338","volume":"14","author":"A Mandawat","year":"2021","unstructured":"Mandawat, A., Chattranukulchai, P., Mandawat, A., Blood, A. J., Ambati, S., Hayes, B., Rehwald, W., Kim, H. W., Heitner, J. F., & Shah, D. J. (2021). Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes. Cardiovascular Imaging, 14(7), 1338\u20131350.","journal-title":"Cardiovascular Imaging"},{"issue":"3","key":"10078_CR54","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1007\/s13277-015-4183-7","volume":"37","author":"F De Iuliis","year":"2016","unstructured":"De Iuliis, F., Salerno, G., Taglieri, L., De Biase, L., Lanza, R., Cardelli, P., & Scarpa, S. (2016). Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients. Tumor Biology, 37(3), 3379\u20133387.","journal-title":"Tumor Biology"},{"issue":"3","key":"10078_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.mric.2019.04.001","volume":"27","author":"TF de Souza","year":"2019","unstructured":"de Souza, T. F., Silva, T. Q. A., Neilan, T. G., & Coelho-Filho, O. R. (2019). Assessment of cardiotoxicity of cancer chemotherapy: The value of cardiac MRI. Magnetic Resonance Imaging Clinics of North America, 27(3), 533.","journal-title":"Magnetic Resonance Imaging Clinics of North America"},{"issue":"1","key":"10078_CR56","volume":"2021","author":"\u0218 Sp\u00eenu","year":"2021","unstructured":"Sp\u00eenu, \u0218, Cismaru, G., Boarescu, P.-M., Istratoaie, S., Negru, A. G., Lazea, C., C\u0103inap, S. S., Iacob, D., Grosu, A. I., & Saraci, G. (2021). ECG markers of cardiovascular toxicity in adult and pediatric cancer treatment. Disease Markers, 2021(1), Article 6653971.","journal-title":"Disease Markers"},{"issue":"1","key":"10078_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2019.12.027","volume":"523","author":"X Yu","year":"2020","unstructured":"Yu, X., Ruan, Y., Huang, X., Dou, L., Lan, M., Cui, J., Chen, B., Gong, H., Wang, Q., & Yan, M. (2020). Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochemical and Biophysical Research Communications, 523(1), 140\u2013146.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10078_CR58","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/annonc\/mdj134","volume":"17","author":"M Marty","year":"2006","unstructured":"Marty, M., Espie, M., Llombart, A., Monnier, A., Rapoport, B., Stahalova, V., Dexrazoxane Study Group. (2006). Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane\u00ae) in advanced\/metastatic breast cancer patients treated with anthracycline-based chemotherapy. Annals of Oncology, 17(4), 614\u2013622.","journal-title":"Annals of Oncology"},{"key":"10078_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv357","author":"F Shaikh","year":"2016","unstructured":"Shaikh, F., Dupuis, L. L., Alexander, S., Gupta, A., Mertens, L., & Nathan, P. C. (2016). Cardioprotection and second malignant neoplasms associated with dexrazoxane in children receiving anthracycline chemotherapy: A systematic review and meta-analysis. Journal of the National Cancer Institute. https:\/\/doi.org\/10.1093\/jnci\/djv357","journal-title":"Journal of the National Cancer Institute"},{"key":"10078_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000514","author":"E Tahover","year":"2017","unstructured":"Tahover, E., Segal, A., Isacson, R., Rosengarten, O., Grenader, T., Gips, M., Cherny, N., Heching, N. I., Mesika, L., Catane, R., & Gabizon, A. (2017). Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: A retrospective cohort study with a comparative analysis of toxicity and survival. Anti-Cancer Drugs. https:\/\/doi.org\/10.1097\/CAD.0000000000000514","journal-title":"Anti-Cancer Drugs"},{"key":"10078_CR61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.breast.2017.10.010","volume":"37","author":"DM Gujral","year":"2018","unstructured":"Gujral, D. M., Lloyd, G., & Bhattacharyya, S. (2018). Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy\u2009\u00b1\u2009trastuzumab. The Breast, 37, 64\u201371.","journal-title":"The Breast"},{"issue":"10","key":"10078_CR62","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.21873\/anticanres.13769","volume":"39","author":"P Georgakopoulos","year":"2019","unstructured":"Georgakopoulos, P., Kyriakidis, M., Perpinia, A., Karavidas, A., Zimeras, S., Mamalis, N., Kouvela, M., & Charpidou, A. (2019). The role of metoprolol and enalapril in the prevention of doxorubicin-induced cardiotoxicity in lymphoma patients. Anticancer Research, 39(10), 5703\u20135707.","journal-title":"Anticancer Research"},{"issue":"1","key":"10078_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2021.2019504","volume":"11","author":"DA Shabaan","year":"2023","unstructured":"Shabaan, D. A., Mostafa, N., El-Desoky, M. M., & Arafat, E. A. (2023). Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway. Tissue Barriers, 11(1), Article 2019504.","journal-title":"Tissue Barriers"},{"issue":"2","key":"10078_CR64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.15171\/jcvtr.2019.21","volume":"11","author":"S Kolivand","year":"2019","unstructured":"Kolivand, S., Amini, P., Saffar, H., Rezapoor, S., Najafi, M., Motevaseli, E., Nouruzi, F., Shabeeb, D., & Musa, A. E. (2019). Selenium-L-methionine modulates radiation injury and Duox1 and Duox2 upregulation in rat\u2019s heart tissues. Journal of Cardiovascular and Thoracic Research, 11(2), 121.","journal-title":"Journal of Cardiovascular and Thoracic Research"},{"issue":"2","key":"10078_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/tjb-2018-0156","volume":"44","author":"T Donia","year":"2019","unstructured":"Donia, T., Eldaly, S., & Ali, E. M. (2019). Ameliorating oxidative stress and inflammation by Hesperidin and vitamin E in doxorubicin induced cardiomyopathy. Turkish Journal of Biochemistry, 44(2), 207\u2013217.","journal-title":"Turkish Journal of Biochemistry"},{"key":"10078_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-025-10030-6","author":"SS TamehriZadeh","year":"2025","unstructured":"TamehriZadeh, S. S., Khalaji, M., Tajdari, M., Mavaddat, H., Szmit, S., Lashgari, N.-A., Roudsari, N. M., Abbasi-Kashkoli, H., Banach, M., & Abdolghaffari, A. H. (2025). Statins: Novel approaches for the management of doxorubicin-induced cardiotoxicity\u2014a literature review. Cardiovascular Toxicology. https:\/\/doi.org\/10.1007\/s12012-025-10030-6","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"10078_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0253-7613.62411","volume":"42","author":"RA Pathan","year":"2010","unstructured":"Pathan, R. A., Singh, B. K., Pillai, K., & Dubey, K. (2010). Naproxen aggravates doxorubicin-induced cardiomyopathy in rats. Indian Journal of Pharmacology, 42(1), 44\u201349.","journal-title":"Indian Journal of Pharmacology"},{"issue":"2","key":"10078_CR68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/FJC.0b013e3181c87e17","volume":"55","author":"BK Singh","year":"2010","unstructured":"Singh, B. K., Pathan, R. A., Pillai, K. K., Haque, S. E., & Dubey, K. (2010). Diclofenac sodium, a nonselective nonsteroidal anti-inflammatory drug aggravates doxorubicin-induced cardiomyopathy in rats. Journal of Cardiovascular Pharmacology, 55(2), 139\u2013144.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"24","key":"10078_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245799","volume":"15","author":"M Aldaly","year":"2023","unstructured":"Aldaly, M., Hussien, A., El-Nadi, I. M., Laz, N. I., Said, A. S., Al-Ahmad, M. M., Hussein, R. R., Rabie, A. S. I., & Shaaban, A. H. (2023). A comparison of 3d conformal and deep inspiratory breath holding vs. 4D-CT intensity-modulated radiation therapy for patients with left breast cancer. Cancers, 15(24), Article 5799.","journal-title":"Cancers"},{"key":"10078_CR70","doi-asserted-by":"crossref","unstructured":"70. Pollom E. L., Chin A. L., Diehn M, Loo BW, Chang D. T. (2017) Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy. In Seminars in radiation oncology (p. 197\u2013208).\u00a0Elsevier","DOI":"10.1016\/j.semradonc.2017.02.001"},{"issue":"6","key":"10078_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100745","volume":"6","author":"J Harms","year":"2021","unstructured":"Harms, J., Zhang, J., Kayode, O., Wolf, J., Tian, S., McCall, N., Higgins, K. A., Castillo, R., & Yang, X. (2021). Implementation of a knowledge-based treatment planning model for cardiac-sparing lung radiation therapy. Advances in Radiation Oncology, 6(6), Article 100745.","journal-title":"Advances in Radiation Oncology"},{"issue":"6","key":"10078_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021). Recent advances in tumor targeting via EPR effect for cancer treatment. Journal of Personalized Medicine, 11(6), Article 571.","journal-title":"Journal of Personalized Medicine"},{"issue":"10","key":"10078_CR73","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41563-023-01630-0","volume":"22","author":"LNM Nguyen","year":"2023","unstructured":"Nguyen, L. N. M., Lin, Z. P., Sindhwani, S., MacMillan, P., Mladjenovic, S. M., Stordy, B., Ngo, W., & Chan, W. C. W. (2023). The exit of nanoparticles from solid tumours. Nature Materials, 22(10), 1261\u20131272.","journal-title":"Nature Materials"},{"key":"10078_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210082","author":"J Kim","year":"2023","unstructured":"Kim, J., Cho, H., Lim, D. K., Joo, M. K., & Kim, K. (2023). Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms241210082","journal-title":"International Journal of Molecular Sciences"},{"key":"10078_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.213147","volume":"142","author":"NG Shetake","year":"2022","unstructured":"Shetake, N. G., Ali, M., Kumar, A., Bellare, J., & Pandey, B. N. (2022). Theranostic magnetic nanoparticles enhance DNA damage and mitigate doxorubicin-induced cardio-toxicity for effective multi-modal tumor therapy. Biomaterials Advances, 142, Article 213147.","journal-title":"Biomaterials Advances"},{"issue":"12","key":"10078_CR76","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.bpj.2019.07.033","volume":"117","author":"A Lewalle","year":"2019","unstructured":"Lewalle, A., Land, S., Merken, J. J., Raafs, A., Sep\u00falveda, P., Heymans, S., Kleinjans, J., & Niederer, S. A. (2019). Balance of active, passive, and anatomical cardiac properties in doxorubicin-induced heart failure. Biophysical Journal, 117(12), 2337\u20132348.","journal-title":"Biophysical Journal"},{"issue":"34","key":"10078_CR77","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.1039\/C9SC01841G","volume":"10","author":"Q Guo","year":"2019","unstructured":"Guo, Q., Wang, Y., Zhang, L., Zhang, P., Yu, Y., Zhang, Y., Li, C., Jiang, S., & Zhang, X. (2019). In situ real-time tracing of hierarchical targeting nanostructures in drug resistant tumors using diffuse fluorescence tomography. Chemical Science, 10(34), 7878\u20137886.","journal-title":"Chemical Science"},{"issue":"7","key":"10078_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10070238","volume":"10","author":"NA Hanafy","year":"2018","unstructured":"Hanafy, N. A., El-Kemary, M., & Leporatti, S. (2018). Micelles structure development as a strategy to improve smart cancer therapy. Cancers, 10(7), Article 238.","journal-title":"Cancers"},{"key":"10078_CR79","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.msec.2016.11.073","volume":"71","author":"SZ Vahed","year":"2017","unstructured":"Vahed, S. Z., Salehi, R., Davaran, S., & Sharifi, S. (2017). Liposome-based drug co-delivery systems in cancer cells. Materials Science and Engineering: C, 71, 1327\u20131341.","journal-title":"Materials Science and Engineering: C"},{"issue":"4","key":"10078_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2025.101058","volume":"25","author":"MF Rad","year":"2025","unstructured":"Rad, M. F., Aghaz, F., Rashidi, K., Gharibnejad, S., Arkan, E., Mansouri, K., Motevaseli, E., & Najafi, M. (2025). Evaluation of the protective effect of resveratrol-loaded solid lipid nanoparticles on radiation-or doxorubicin-induced spermatogenic damage in mice. Reproductive Biology, 25(4), Article 101058.","journal-title":"Reproductive Biology"},{"key":"10078_CR81","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S365974","volume":"17","author":"AY Sherif","year":"2022","unstructured":"Sherif, A. Y., Harisa, G. I., Alanazi, F. K., Nasr, F. A., & Alqahtani, A. S. (2022). PEGylated SLN as a promising approach for lymphatic delivery of gefitinib to lung cancer. International Journal of Nanomedicine, 17, Article 3287.","journal-title":"International Journal of Nanomedicine"},{"key":"10078_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101506","volume":"56","author":"M Cagel","year":"2020","unstructured":"Cagel, M., Moretton, M. A., Bernabeu, E., Zubillaga, M., Lagomarsino, E., Vanzulli, S., Nicoud, M. B., Medina, V. A., Salgueiro, M. J., & Chiappetta, D. A. (2020). Antitumor efficacy and cardiotoxic effect of doxorubicin-loaded mixed micelles in 4T1 murine breast cancer model. Comparative studies using Doxil\u00ae and free doxorubicin. Journal of Drug Delivery Science and Technology, 56, Article 101506.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"9","key":"10078_CR83","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024). Polymeric nanoparticles for drug delivery. Chemical Reviews, 124(9), 5505\u20135616.","journal-title":"Chemical Reviews"},{"issue":"3","key":"10078_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030474","volume":"14","author":"J Kim","year":"2022","unstructured":"Kim, J., Choi, Y., Yang, S., Lee, J., Choi, J., Moon, Y., Kim, J., Shim, N., Cho, H., & Shim, M. K. (2022). Sustained and long-term release of doxorubicin from PLGA nanoparticles for eliciting anti-tumor immune responses. Pharmaceutics, 14(3), Article 474.","journal-title":"Pharmaceutics"},{"key":"10078_CR85","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.ijbiomac.2014.10.052","volume":"72","author":"M Prabaharan","year":"2015","unstructured":"Prabaharan, M. (2015). Chitosan-based nanoparticles for tumor-targeted drug delivery. International Journal of Biological Macromolecules, 72, 1313\u20131322.","journal-title":"International Journal of Biological Macromolecules"},{"issue":"18","key":"10078_CR86","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2217\/nnm-2016-0154","volume":"11","author":"M Hadla","year":"2016","unstructured":"Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2016). Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine, 11(18), 2431\u20132441.","journal-title":"Nanomedicine"},{"issue":"1","key":"10078_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3301","volume":"28","author":"C Diaferia","year":"2022","unstructured":"Diaferia, C., Rosa, E., Accardo, A., & Morelli, G. (2022). Peptide-based hydrogels as delivery systems for doxorubicin. Journal of Peptide Science, 28(1), Article e3301.","journal-title":"Journal of Peptide Science"},{"issue":"6","key":"10078_CR88","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ddr.21399","volume":"78","author":"Y Sun","year":"2017","unstructured":"Sun, Y., Kang, C., Liu, F., Zhou, Y., Luo, L., & Qiao, H. (2017). RGD peptide-based target drug delivery of doxorubicin nanomedicine. Drug Development Research, 78(6), 283\u2013291.","journal-title":"Drug Development Research"},{"issue":"12","key":"10078_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019). Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells, 8(12), Article 1605.","journal-title":"Cells"},{"issue":"5","key":"10078_CR90","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00281-018-0682-0","volume":"40","author":"EI Buz\u00e1s","year":"2018","unstructured":"Buz\u00e1s, E. I., T\u00f3th, E. \u00c1., S\u00f3dar, B. W., & Szab\u00f3-Taylor, K. \u00c9. (2018). Molecular interactions at the surface of extracellular vesicles. Seminars in Immunopathology, 40(5), 453\u2013464.","journal-title":"Seminars in Immunopathology"},{"issue":"14","key":"10078_CR91","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1039\/C8NR08720B","volume":"11","author":"AF Saleh","year":"2019","unstructured":"Saleh, A. F., L\u00e1zaro-Ib\u00e1\u00f1ez, E., Forsgard, M. A. M., Shatnyeva, O., Osteikoetxea, X., Karlsson, F., Heath, N., Ingelsten, M., Rose, J., Harris, J., Mairesse, M., Bates, S. M., Clausen, M., Etal, D., Leonard, E., Fellows, M. D., Dekker, N., & Edmunds, N. (2019). Extracellular vesicles induce minimal hepatotoxicity and immunogenicity. Nanoscale, 11(14), 6990\u20137001.","journal-title":"Nanoscale"},{"issue":"6","key":"10078_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1886","volume":"15","author":"K Moloudi","year":"2023","unstructured":"Moloudi, K., Khani, A., Najafi, M., Azmoonfar, R., Azizi, M., Nekounam, H., Sobhani, M., Laurent, S., & Samadian, H. (2023). Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic. WIREs Nanomedicine and Nanobiotechnology, 15(6), Article e1886.","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"issue":"20","key":"10078_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/nano14201647","volume":"14","author":"PL Dulf","year":"2024","unstructured":"Dulf, P. L., Coad\u0103, C. A., Florea, A., Moldovan, R., Baldea, I., Dulf, D. V., Blendea, D., David, L., Moldovan, B., & Morosan, V. I. (2024). Doxorubicin incorporation into gold nanoparticles: An in vivo study of its effects on cardiac tissue in rats. Nanomaterials, 14(20), Article 1647.","journal-title":"Nanomaterials"},{"issue":"1","key":"10078_CR94","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1021\/acsami.7b14705","volume":"10","author":"Q Yang","year":"2018","unstructured":"Yang, Q., Peng, J., Xiao, Y., Li, W., Tan, L., Xu, X., & Qian, Z. (2018). Porous Au@ Pt nanoparticles: Therapeutic platform for tumor chemo-photothermal co-therapy and alleviating doxorubicin-induced oxidative damage. ACS Applied Materials & Interfaces, 10(1), 150\u2013164.","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"29","key":"10078_CR95","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1039\/C5NR02718G","volume":"7","author":"CA Quinto","year":"2015","unstructured":"Quinto, C. A., Mohindra, P., Tong, S., & Bao, G. (2015). Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment. Nanoscale, 7(29), 12728\u201312736.","journal-title":"Nanoscale"},{"issue":"4","key":"10078_CR96","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1016\/j.ceramint.2020.10.022","volume":"47","author":"Y He","year":"2021","unstructured":"He, Y., Shao, L., Hu, Y., Zhao, F., Tan, S., He, D., & Pan, A. (2021). Redox and pH dual-responsive biodegradable mesoporous silica nanoparticle as a potential drug carrier for synergistic cancer therapy. Ceramics International, 47(4), 4572\u20134578.","journal-title":"Ceramics International"},{"issue":"2\u20133","key":"10078_CR97","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/tcr.201800038","volume":"19","author":"B Hosnedlova","year":"2019","unstructured":"Hosnedlova, B., Kepinska, M., Fernandez, C., Peng, Q., Ruttkay-Nedecky, B., Milnerowicz, H., & Kizek, R. (2019). Carbon nanomaterials for targeted cancer therapy drugs: A critical review. The Chemical Record, 19(2\u20133), 502\u2013522.","journal-title":"The Chemical Record"},{"key":"10078_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.rsurfi.2025.100473","volume":"19","author":"MZ Ahmad","year":"2025","unstructured":"Ahmad, M. Z., Mustafa, G., Abdel-Wahab, B. A., Pathak, K., Das, A., Sahariah, J. J., Kalita, P., Alam, A., & Borthakur, P. P. (2025). From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. Results in Surfaces and Interfaces, 19, Article 100473.","journal-title":"Results in Surfaces and Interfaces"},{"issue":"5","key":"10078_CR99","first-page":"566","volume":"18","author":"J Mangana","year":"2008","unstructured":"Mangana, J., Zipser, M. C., Conrad, C., Oberholzer, P. A., Cozzio, A., Knuth, A., French, L. E., & Dummer, R. (2008). Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome. European Journal of Dermatology, 18(5), 566\u2013570.","journal-title":"European Journal of Dermatology"},{"issue":"3 Suppl 1","key":"10078_CR100","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1590\/abd1806-4841.20153708","volume":"90","author":"H Ma","year":"2015","unstructured":"Ma, H., Chen, M., Liu, J., Li, Y., & Li, J. (2015). Serious stomatitis and esophagitis: A peculiar mucous reaction induced by pegylated liposomal doxorubicin. Anais Brasileiros de Dermatologia, 90(3 Suppl 1), 209\u2013211.","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10078_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115836","volume":"168","author":"L Wang","year":"2023","unstructured":"Wang, L., Xu, X., Chu, L., Meng, C., Xu, L., Wang, Y., Jiao, Q., Huang, T., Zhao, Y., Liu, X., Li, J., Zhou, B., & Wang, T. (2023). PEG-modified carbon-based nanoparticles as tumor-targeted drug delivery system reducing doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy, 168, Article 115836.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"12","key":"10078_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051960","volume":"7","author":"K Golla","year":"2012","unstructured":"Golla, K., Cherukuvada, B., Ahmed, F., & Kondapi, A. K. (2012). Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats. PLoS One, 7(12), Article e51960.","journal-title":"PLoS One"},{"issue":"6","key":"10078_CR103","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3892\/or.2016.4748","volume":"35","author":"C Sun","year":"2016","unstructured":"Sun, C., Zhou, L., Gou, M., Shi, S., Li, T., & Lang, J. (2016). Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles. Oncology Reports, 35(6), 3600\u20133606.","journal-title":"Oncology Reports"},{"issue":"1","key":"10078_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94291-9","volume":"15","author":"A Ghahremanloo","year":"2025","unstructured":"Ghahremanloo, A., Erfani, B., Asgharzadeh, F., Mansoori, S., Gheybi, F., & Hashemy, S. I. (2025). Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer. Scientific Reports, 15(1), Article 9798.","journal-title":"Scientific Reports"},{"key":"10078_CR105","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.msec.2018.05.073","volume":"91","author":"Y Li","year":"2018","unstructured":"Li, Y., Lin, J., Zhi, X., Li, P., Jiang, X., & Yuan, J. (2018). Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release. Materials Science and Engineering: C, 91, 606\u2013614.","journal-title":"Materials Science and Engineering: C"},{"issue":"1","key":"10078_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-023-00205-7","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q., Zhang, L., Li, Y., Wang, J., He, X., Zhang, J., Qiao, Y., Wu, H., & Zhu, L. (2023). Targeting and sensitizing MDR cancer by an MMP2 and pH dual-responsive ZnO-based nanomedicine. Cancer Nanotechnology, 14(1), Article 56.","journal-title":"Cancer Nanotechnology"},{"issue":"19","key":"10078_CR107","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1039\/D3NR06269D","volume":"16","author":"N Drinkovi\u0107","year":"2024","unstructured":"Drinkovi\u0107, N., Beus, M., Barbir, R., Debeljak, \u017d, Lovakovi\u0107, B. T., Kal\u010dec, N., \u0106urlin, M., Bekavac, A., Gorup, D., & Mami\u0107, I. (2024). Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity. Nanoscale, 16(19), 9412\u20139425.","journal-title":"Nanoscale"},{"issue":"2","key":"10078_CR108","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jconrel.2005.03.030","volume":"107","author":"X-B Xiong","year":"2005","unstructured":"Xiong, X.-B., Huang, Y., Lu, W.-l, Zhang, X., Zhang, H., Nagai, T., & Zhang, Q. (2005). Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. Journal of Controlled Release, 107(2), 262\u2013275.","journal-title":"Journal of Controlled Release"},{"key":"10078_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2022.112487","volume":"233","author":"C Mo","year":"2022","unstructured":"Mo, C., Wang, Z., Yang, J., Ouyang, Y., Mo, Q., Li, S., He, P., Chen, L., & Li, X. (2022). Rational assembly of RGD\/MoS2\/Doxorubicin nanodrug for targeted drug delivery, GSH-stimulus release and chemo-photothermal synergistic antitumor activity. Journal of Photochemistry and Photobiology, B: Biology, 233, Article 112487.","journal-title":"Journal of Photochemistry and Photobiology, B: Biology"},{"key":"10078_CR110","volume":"12","author":"N Mokhtar","year":"2023","unstructured":"Mokhtar, N., Fouda, F., Zaazaa, A. M., & Mahmoud, M. H. (2023). Nano-encapsulation of doxorubicin using pectin: Safety an activity on chemotherapy-induced cardiotoxicity in carcinoma mice. Letters in Applied NanoBioScience, 12, Article 107.","journal-title":"Letters in Applied NanoBioScience"},{"key":"10078_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030901","author":"M Szwed","year":"2025","unstructured":"Szwed, M., Poczta-Krawczyk, A., Kania, K. D., Wiktorowski, K., Podsiad\u0142o, K., Marczak, A., & Szczepanowicz, K. (2025). Multicore, SDS-based polyelectrolyte nanocapsules as novel nanocarriers for paclitaxel to reduce cardiotoxicity by protecting the mitochondria. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms26030901","journal-title":"International Journal of Molecular Sciences"},{"key":"10078_CR112","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4028\/www.scientific.net\/AMR.912-914.263","volume":"912","author":"JN Mao","year":"2014","unstructured":"Mao, J. N., Li, A. J., Zhao, L. P., Gao, L., Xu, W. T., Hong, X. S., Jiang, W. P., & Chen, J. C. (2014). PEG-PLGA nanoparticles entrapping doxorubicin reduced doxorubicin-induced cardiotoxicity in rats. Advanced Materials Research, 912, 263\u2013268.","journal-title":"Advanced Materials Research"},{"key":"10078_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ma15113960","author":"HF Al-Thani","year":"2022","unstructured":"Al-Thani, H. F., Shurbaji, S., Zakaria, Z. Z., Hasan, M. H., Goracinova, K., Korashy, H. M., & Yalcin, H. C. (2022). Reduced cardiotoxicity of Ponatinib-loaded PLGA-PEG-PLGA nanoparticles in zebrafish xenograft model. Materials (Basel). https:\/\/doi.org\/10.3390\/ma15113960","journal-title":"Materials (Basel)"},{"key":"10078_CR114","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.actbio.2021.06.016","volume":"131","author":"QT Shubhra","year":"2021","unstructured":"Shubhra, Q. T., Guo, K., Liu, Y., Razzak, M., Manir, M. S., & Alam, A. M. (2021). Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity. Acta Biomaterialia, 131, 493\u2013507.","journal-title":"Acta Biomaterialia"},{"key":"10078_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-025-02471-3","author":"M Suliman","year":"2025","unstructured":"Suliman, M., Altalbawy, F. M. A., Kazmi, S. W., Sharma, A., Kumar, M. R., Alamir, H. T. A., Mohammed, F., Kadhim, A. J., & Alhadrawi, M. (2025). Chemo-\/radiotherapy-induced cardiomyopathy: roles of mitochondria and endoplasmic reticulum. Strahlentherapie und Onkologie. https:\/\/doi.org\/10.1007\/s00066-025-02471-3","journal-title":"Strahlentherapie und Onkologie"},{"issue":"18","key":"10078_CR116","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1016\/j.biomaterials.2010.02.068","volume":"31","author":"JH Maeng","year":"2010","unstructured":"Maeng, J. H., Lee, D.-H., Jung, K. H., Bae, Y.-H., Park, I.-S., Jeong, S., Jeon, Y.-S., Shim, C.-K., Kim, W., Kim, J., Lee, J., Lee, Y.-M., Kim, J.-H., Kim, W.-H., & Hong, S.-S. (2010). Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials, 31(18), 4995\u20135006.","journal-title":"Biomaterials"},{"issue":"2","key":"10078_CR117","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ehf2.12616","volume":"7","author":"R Tanaka","year":"2020","unstructured":"Tanaka, R., Umemura, M., Narikawa, M., Hikichi, M., Osaw, K., Fujita, T., Yokoyama, U., Ishigami, T., Tamura, K., & Ishikawa, Y. (2020). Reactive fibrosis precedes doxorubicin-induced heart failure through sterile inflammation. ESC Heart Failure, 7(2), 588\u2013603.","journal-title":"ESC Heart Failure"},{"key":"10078_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115836","volume":"168","author":"L Wang","year":"2023","unstructured":"Wang, L., Xu, X., Chu, L., Meng, C., Xu, L., Wang, Y., Jiao, Q., Huang, T., Zhao, Y., & Liu, X. (2023). PEG-modified carbon-based nanoparticles as tumor-targeted drug delivery system reducing doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy, 168, Article 115836.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"5","key":"10078_CR119","first-page":"970","volume":"116","author":"M Gy\u00f6ngy\u00f6si","year":"2020","unstructured":"Gy\u00f6ngy\u00f6si, M., Lukovic, D., Zlabinger, K., Spannbauer, A., Gugerell, A., Pavo, N., Traxler, D., Pils, D., Maurer, G., & Jakab, A. (2020). Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance. Cardiovascular Research, 116(5), 970\u2013982.","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10078_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3260-6","volume":"11","author":"C Stark","year":"2018","unstructured":"Stark, C., Taimen, P., Savunen, T., & Koskenvuo, J. (2018). Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice. BMC Research Notes, 11(1), Article 148.","journal-title":"BMC Research Notes"},{"issue":"32","key":"10078_CR121","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1039\/C8TB01136B","volume":"6","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Zong, W., Cheng, W., & Han, X. (2018). Codelivery of doxorubicin and sodium tanshinone IIA sulfonate using multicompartmentalized vesosomes to enhance synergism and prevent doxorubicin-induced cardiomyocyte apoptosis. Journal of Materials Chemistry B, 6(32), 5243\u20135247.","journal-title":"Journal of Materials Chemistry B"},{"key":"10078_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.113992","volume":"241","author":"Q Jin","year":"2024","unstructured":"Jin, Q., Zhou, X., Niu, X., Ping, C., Dong, X., Duan, D., Wang, R., Chen, Y., Pan, F., Yang, F., Yang, X., Zhang, G., Wang, R., Zhang, S., & Ren, G. (2024). Co-delivery of doxorubicin-dihydroartemisinin prodrug\/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice. Colloids and Surfaces B: Biointerfaces, 241, Article 113992.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"10078_CR123","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/IJN.S187888","volume":"14","author":"Y Li","year":"2019","unstructured":"Li, Y., Yang, D., Wang, Y., Li, Z., & Zhu, C. (2019). Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency. International Journal of Nanomedicine, 14, 301\u2013315.","journal-title":"International Journal of Nanomedicine"},{"key":"10078_CR124","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejpb.2016.11.033","volume":"112","author":"W Ma","year":"2017","unstructured":"Ma, W., Guo, Q., Li, Y., Wang, X., Wang, J., & Tu, P. (2017). Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. European Journal of Pharmaceutics and Biopharmaceutics, 112, 209\u2013223.","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10078_CR125","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.2147\/IJN.S170067","volume":"13","author":"D Zhang","year":"2018","unstructured":"Zhang, D., Xu, Q., Wang, N., Yang, Y., Liu, J., Yu, G., Yang, X., Xu, H., & Wang, H. (2018). A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth. International Journal of Nanomedicine, 13, 4549\u20134561.","journal-title":"International Journal of Nanomedicine"},{"key":"10078_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110876","volume":"132","author":"EB Lages","year":"2020","unstructured":"Lages, E. B., Fernandes, R. S., Silva, Jd. O., de Souza, \u00c2. M., Cassali, G. D., de Barros, A. L. B., & Miranda Ferreira, L. A. (2020). Co-delivery of doxorubicin, docosahexaenoic acid, and \u03b1-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity. Biomedicine & Pharmacotherapy, 132, Article 110876.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"11","key":"10078_CR127","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1177\/0960327120930266","volume":"39","author":"H Abo Mansour","year":"2020","unstructured":"Abo Mansour, H., El-Batsh, M., Badawy, N., Mehanna, E., Mesbah, N., & Abo-Elmatty, D. (2020). Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice. Human & Experimental Toxicology, 39(11), 1528\u20131544.","journal-title":"Human & Experimental Toxicology"},{"key":"10078_CR128","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nano.2019.03.011","volume":"19","author":"AA Fatease","year":"2019","unstructured":"Fatease, A. A., Shah, V., Nguyen, D. X., Cote, B., LeBlanc, N., Rao, D. A., & Alani, A. W. G. (2019). Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin\/resveratrol and resveratrol\/curcumin in ovarian cancer. Nanomedicine\u202f: Nanotechnology, Biology, and Medicine, 19, 39\u201348.","journal-title":"Nanomedicine : Nanotechnology, Biology, and Medicine"},{"issue":"8","key":"10078_CR129","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/jps.24042","volume":"103","author":"LJ Carlson","year":"2014","unstructured":"Carlson, L. J., Cote, B., Alani, A. W. G., & Rao, D. A. (2014). Polymeric micellar co-delivery of Resveratrol and Curcumin to mitigate In Vitro doxorubicin-induced cardiotoxicity. Journal of Pharmaceutical Sciences, 103(8), 2315\u20132322.","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10078_CR130","volume":"9","author":"T Wang","year":"2025","unstructured":"Wang, T., Li, Z., Lei, J., Zhang, Y., Tong, Y., Guan, X., & Wang, S. (2025). RGD peptide-functionalized micelles loaded with crocetin ameliorate doxorubicin-induced cardiotoxicity. International Journal of Pharmaceutics: X, 9, Article 100326.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"17","key":"10078_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415227","volume":"12","author":"J Huang","year":"2025","unstructured":"Huang, J., Yang, J., Yang, Y., Lu, X., Xu, J., Lu, S., Pan, H., Zhou, W., Li, W., & Chen, S. (2025). Mitigating doxorubicin-induced cardiotoxicity and enhancing anti-tumor efficacy with a Metformin-Integrated Self-Assembled Nanomedicine. Advanced Science, 12(17), Article e2415227.","journal-title":"Advanced Science"},{"issue":"6","key":"10078_CR132","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/bcpt.13648","volume":"129","author":"C Yu","year":"2021","unstructured":"Yu, C., Yang, B., & Najafi, M. (2021). Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy. Basic & Clinical Pharmacology & Toxicology, 129(6), 397\u2013415.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10078_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107895","volume":"98","author":"Q Mu","year":"2021","unstructured":"Mu, Q., & Najafi, M. (2021). Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells. International Immunopharmacology, 98, Article 107895.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10078_CR134","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-022-04502-4","volume":"478","author":"X-y Wu","year":"2023","unstructured":"Wu, X.-y, Xu, W.-W., Huan, X.-k, Wu, G.-n, Li, G., Zhou, Y.-H., & Najafi, M. (2023). Mechanisms of cancer cell killing by metformin: A review on different cell death pathways. Molecular and Cellular Biochemistry, 478(1), 197\u2013214.","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10078_CR135","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/08982104.2019.1580720","volume":"30","author":"J Zhu","year":"2020","unstructured":"Zhu, J., Hu, Q., & Shen, S. (2020). Enhanced antitumor efficacy and attenuated cardiotoxicity of doxorubicin in combination with lycopene liposomes. Journal of Liposome Research, 30(1), 37\u201344.","journal-title":"Journal of Liposome Research"},{"issue":"21","key":"10078_CR136","doi-asserted-by":"publisher","first-page":"18981","DOI":"10.1021\/acs.jmedchem.4c01431","volume":"67","author":"X Yang","year":"2024","unstructured":"Yang, X., Lu, W., de Alves Souza, R. W., Mao, Q., Baram, D., Tripathi, R., Wang, G., Otterbein, L. E., & Wang, B. (2024). Metal-free CO prodrugs activated by molecular oxygen protect against doxorubicin-induced cardiomyopathy in mice. Journal of Medicinal Chemistry, 67(21), 18981\u201318992.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"6","key":"10078_CR137","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12012-021-09636-3","volume":"21","author":"YA Khadrawy","year":"2021","unstructured":"Khadrawy, Y. A., Hosny, E. N., El-Gizawy, M. M., Sawie, H. G., & Aboul Ezz, H. S. (2021). The effect of curcumin nanoparticles on cisplatin-induced cardiotoxicity in male Wistar albino rats. Cardiovascular Toxicology, 21(6), 433\u2013443.","journal-title":"Cardiovascular Toxicology"},{"key":"10078_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.160005","volume":"506","author":"K Jin","year":"2025","unstructured":"Jin, K., Shi, S., Huang, D., Huang, H., Zou, B., Huang, W., & Chen, T. (2025). Maintaining cardiac homeostasis by translational selenium nanoparticles with rapid selenoproteins regulation to achieve radiation-induced heart prevention. Chemical Engineering Journal, 506, Article 160005.","journal-title":"Chemical Engineering Journal"},{"issue":"1","key":"10078_CR139","first-page":"83","volume":"27","author":"RH El-Gebaly","year":"2018","unstructured":"El-Gebaly, R. H., Rageh, M. M., & Maamoun, I. K. (2018). Radio-protective potential of lipoic acid free and nano-capsule against 99mTc-MIBI induced injury in cardio vascular tissue. Journal of X-Ray Science and Technology, 27(1), 83\u201396.","journal-title":"Journal of X-Ray Science and Technology"},{"issue":"36","key":"10078_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902642","volume":"15","author":"C Dai","year":"2019","unstructured":"Dai, C., He, L., Ma, B., & Chen, T. (2019). Facile nanolization strategy for therapeutic Ganoderma lucidum spore oil to achieve enhanced protection against radiation-induced heart disease. Small (Weinheim an der Bergstrasse, Germany), 15(36), Article e1902642.","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10078_CR141","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bioactmat.2024.03.034","volume":"37","author":"C Liu","year":"2024","unstructured":"Liu, C., Wang, W., Lai, H., Chen, Y., Li, L., Li, H., Zhan, M., Chen, T., Cao, W., & Li, X. (2024). Biosynthesis of fungus-based oral selenium microcarriers for radioprotection and immuno-homeostasis shaping against radiation-induced heart disease. Bioactive Materials, 37, 393\u2013406.","journal-title":"Bioactive Materials"},{"issue":"9","key":"10078_CR142","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1007\/s00210-024-03052-4","volume":"397","author":"HM Karam","year":"2024","unstructured":"Karam, H. M., Lotfy, D. M., A. Ibrahim, A., Mosallam, F. M., Abdelrahman, S. S., & Abd-ElRaouf, A. (2024). A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1\/TGF-\u0392 pathway. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 397(9), 6919\u20136927.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"2","key":"10078_CR143","first-page":"383","volume":"116","author":"G Milano","year":"2020","unstructured":"Milano, G., Biemmi, V., Lazzarini, E., Balbi, C., Ciullo, A., Bolis, S., Ameri, P., Di Silvestre, D., Mauri, P., & Barile, L. (2020). Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin\/trastuzumab-induced cardiac toxicity. Cardiovascular Research, 116(2), 383\u2013392.","journal-title":"Cardiovascular Research"},{"issue":"7","key":"10078_CR144","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/jemt.24544","volume":"87","author":"RAEN Imam","year":"2024","unstructured":"Imam, R. A. E. N., Aboulhoda, B. E., Amer, M. M., Hassan, F. E., Alghamdi, M. A., & Abdel-Hamed, M. R. (2024). Role of mesenchymal stem cells-derived exosomes on inflammation, apoptosis, fibrosis and telocyte modulation in doxorubicin-induced cardiotoxicity: A closer look at the structural level. Microscopy Research and Technique, 87(7), 1598\u20131614.","journal-title":"Microscopy Research and Technique"},{"issue":"10","key":"10078_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101224","volume":"8","author":"DK Singla","year":"2019","unstructured":"Singla, D. K., Johnson, T. A., & Tavakoli Dargani, Z. (2019). Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy. Cells, 8(10), Article 1224.","journal-title":"Cells"},{"issue":"1","key":"10078_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010093","volume":"17","author":"SA Ali","year":"2024","unstructured":"Ali, S. A., & Singla, D. K. (2024). Mesenchymal stem cell-derived exosomes ameliorate doxorubicin-induced cardiotoxicity. Pharmaceuticals, 17(1), Article 93.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10078_CR147","doi-asserted-by":"publisher","first-page":"H460","DOI":"10.1152\/ajpheart.00056.2019","volume":"317","author":"Z Tavakoli Dargani","year":"2019","unstructured":"Tavakoli Dargani, Z., & Singla, D. K. (2019). Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis. American Journal of Physiology. Heart and Circulatory Physiology, 317(2), H460-h471.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"17","key":"10078_CR148","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020589","volume":"10","author":"B Lei","year":"2021","unstructured":"Lei, B., Wu, X., Xia, K., Sun, H., & Wang, J. (2021). Exosomal micro-RNA\u201096 derived from bone marrow mesenchymal stem cells inhibits doxorubicin\u2010induced myocardial toxicity by inhibiting the Rac1\/Nuclear Factor\u2010\u03baB signaling pathway. Journal of the American Heart Association, 10(17), Article e020589.","journal-title":"Journal of the American Heart Association"},{"key":"10078_CR149","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2022.10.268","volume":"193","author":"Y Yu","year":"2022","unstructured":"Yu, Y., Wu, T., Lu, Y., Zhao, W., Zhang, J., Chen, Q., Ge, G., Hua, Y., Chen, K., & Ullah, I. (2022). Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling. Free Radical Biology and Medicine, 193, 108\u2013121.","journal-title":"Free Radical Biology and Medicine"},{"key":"10078_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134495","volume":"277","author":"Z Wen","year":"2024","unstructured":"Wen, Z., Qin, S., Huang, H., Xia, X., Zhang, W., & Wu, W. (2024). Functional exosomes modified with chitosan effectively alleviate anthracycline-induced cardiotoxicity. International Journal of Biological Macromolecules, 277, Article 134495.","journal-title":"International Journal of Biological Macromolecules"},{"key":"10078_CR151","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.2147\/JIR.S358471","volume":"15","author":"C Tian","year":"2022","unstructured":"Tian, C., Yang, Y., Li, B., Liu, M., He, X., Zhao, L., Song, X., Yu, T., & Chu, X.-M. (2022). Doxorubicin-induced cardiotoxicity may be alleviated by bone marrow mesenchymal stem cell-derived exosomal lncRNA via inhibiting inflammation. Journal of Inflammation Research, 15, 4467\u20134486.","journal-title":"Journal of Inflammation Research"},{"issue":"21","key":"10078_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113465","volume":"23","author":"C Yarana","year":"2022","unstructured":"Yarana, C., Siwaponanan, P., Maneechote, C., Khuanjing, T., Ongnok, B., Prathumsap, N., Chattipakorn, S. C., Chattipakorn, N., & Pattanapanyasat, K. (2022). Extracellular vesicles released after doxorubicin treatment in rats protect cardiomyocytes from oxidative damage and induce pro-inflammatory gene expression in macrophages. International Journal of Molecular Sciences, 23(21), Article 13465.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10078_CR153","first-page":"428","volume":"3","author":"CG O'Brien","year":"2021","unstructured":"O\u2019Brien, C. G., Ozen, M. O., Ikeda, G., Vaskova, E., Jung, J. H., Bayardo, N., Santoso, M. R., Shi, L., Wahlquist, C., Jiang, Z., Jung, Y., Zeng, Y., Egan, E., Sinclair, R., Gee, A., Witteles, R., Mercola, M., Svensson, K. J., Demirci, U., & Yang, P. C. (2021). Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: Insights into the SENECA Trial. JACC: CardioOncology, 3(3), 428\u2013440.","journal-title":"JACC: CardioOncology"},{"issue":"1","key":"10078_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-025-00664-5","volume":"20","author":"WT Hsu","year":"2025","unstructured":"Hsu, W. T., Kobuchi, S., Chien, T. R., Chen, I. C., Hamada, S., Tsujimoto, M., Tsai, I. L., Wong, Y. S., Tung, K. H., & He, Y. Z. (2025). Extracellular vesicle-enriched secretome of adipose-derived stem cells upregulates clusterin to alleviate doxorubicin-induced apoptosis in cardiomyocytes. Biology Direct, 20(1), Article 84.","journal-title":"Biology Direct"},{"issue":"1","key":"10078_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02705-z","volume":"22","author":"C Ye","year":"2024","unstructured":"Ye, C., Yan, C., Bian, S. J., Li, X. R., Li, Y., Wang, K. X., Zhu, Y. H., Wang, L., Wang, Y. C., Wang, Y. Y., Li, T. S., Qi, S. H., & Luo, L. (2024). Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity. Journal of Nanobiotechnology, 22(1), Article 464.","journal-title":"Journal of Nanobiotechnology"},{"issue":"13","key":"10078_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137102","volume":"22","author":"JY Lee","year":"2021","unstructured":"Lee, J. Y., Chung, J., Byun, Y., Kim, K. H., An, S. H., & Kwon, K. (2021). Mesenchymal stem cell-derived small extracellular vesicles protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin expression via the miR-199a-3p-Akt-Sp1\/p53 signaling pathway. International Journal of Molecular Sciences, 22(13), Article 7102.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10078_CR157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12012-022-09774-2","volume":"23","author":"J Duan","year":"2023","unstructured":"Duan, J., Liu, X., Shen, S., Tan, X., Wang, Y., Wang, L., Kang, L., Wang, K., Wei, Z., Qi, Y., Hu, L., Xu, B., & Gu, R. (2023). Trophoblast stem-cell-derived exosomes alleviate cardiotoxicity of doxorubicin via improving Mfn2-mediated mitochondrial fusion. Cardiovascular Toxicology, 23(1), 23\u201331.","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"10078_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04115-2","volume":"15","author":"H Cao","year":"2024","unstructured":"Cao, H., Yue, L., Shao, J., Kong, F., Liu, S., Huai, H., He, Z., Mao, Z., Yang, Y., Tan, Y., & Wang, H. (2024). Small extracellular vesicles derived from umbilical cord mesenchymal stem cells alleviate radiation-induced cardiac organoid injury. Stem Cell Research & Therapy, 15(1), Article 493.","journal-title":"Stem Cell Research & Therapy"},{"key":"10078_CR159","doi-asserted-by":"publisher","first-page":"864188","DOI":"10.3389\/fcvm.2022.864188","volume":"9","author":"WW Cui","year":"2022","unstructured":"Cui, W. W., Ye, C., Wang, K. X., Yang, X., Zhu, P. Y., Hu, K., & Luo, L. (2022). Momordica charantia-derived extracellular vesicles-like nanovesicles protect cardiomyocytes against radiation injury via attenuating DNA damage and mitochondria dysfunction. Frontiers in Cardiovascular Medicine, 9, 864188.","journal-title":"Frontiers in Cardiovascular Medicine"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-10078-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:04:31Z","timestamp":1769231071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-10078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10078"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-10078-4","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"5"}}